Research Report Screener Results

Chart, Financials, Historical Prices, Industry, Messages, Profile, Reports, more...

Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 10-Feb-2010
New Screen

All Reports | Brokerage Reports | Independent Reports

All Reports (Showing 1 to 10 of 10)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
6-Feb-10 Standard & Poor's Quantitative Report N/A Oncolytics Biotech 6 $25 View Abstract
5-Feb-10 Jefferson Research N/A Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of ONCOLYTICS BIOTECH INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation. 11 $20 View Abstract
2-Feb-10 EconomicInvestor N/A "The Economy Matters" Report for ONCY: the economy's impact on ONCY's price and risk, featuring the powerful EconomicInvestor Star Rating 6 $15 View Abstract
31-Dec-09 Zacks Investment Research Inc. N/A ONCOLYTICS BIO (ONCY) Zacks Company Snapshot 1 $10 View Abstract
30-Dec-09 Zacks Investment Research Inc. N/A ONCOLYTICS BIO (ONCY) Zacks Company Snapshot 1 $10 View Abstract
30-Mar-09 ValuEngine, Inc. N/A ValuEngine Detailed Valuation Report for ONCY 13 $25 View Abstract
29-Mar-09 PriceTarget Research, Inc. N/A Drug Intelligence Monitor: overall outlook VERY STRONG - 25 new Leaders; 10 new Laggards. 50 $20 View Abstract
28-Mar-09 Pechala's Reports Frantisek Pechala ONCOLYTICS BIOTECH INC (ONCY=US) 12-months forecast 1 $15 View Abstract
28-Mar-09 Pechala's Reports Lubomir Pechala ONCOLYTICS BIOTECH INC (ONCY=US) 2-weeks forecast 1 $10 View Abstract
27-Mar-09 Zacks Investment Research Inc. N/A ONCOLYTICS BIO (ONCY) Zacks Company Snapshot 1 $10 View Abstract

Independent Reports (Showing 1 to 10 of 10)

Release
Date Contributor Author Title Pages Price More Info
6-Feb-10 Standard & Poor's Quantitative Report N/A Oncolytics Biotech 6 $25 View Abstract
5-Feb-10 Jefferson Research N/A Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of ONCOLYTICS BIOTECH INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation. 11 $20 View Abstract
2-Feb-10 EconomicInvestor N/A "The Economy Matters" Report for ONCY: the economy's impact on ONCY's price and risk, featuring the powerful EconomicInvestor Star Rating 6 $15 View Abstract
31-Dec-09 Zacks Investment Research Inc. N/A ONCOLYTICS BIO (ONCY) Zacks Company Snapshot 1 $10 View Abstract
30-Dec-09 Zacks Investment Research Inc. N/A ONCOLYTICS BIO (ONCY) Zacks Company Snapshot 1 $10 View Abstract
30-Mar-09 ValuEngine, Inc. N/A ValuEngine Detailed Valuation Report for ONCY 13 $25 View Abstract
29-Mar-09 PriceTarget Research, Inc. N/A Drug Intelligence Monitor: overall outlook VERY STRONG - 25 new Leaders; 10 new Laggards. 50 $20 View Abstract
28-Mar-09 Pechala's Reports Frantisek Pechala ONCOLYTICS BIOTECH INC (ONCY=US) 12-months forecast 1 $15 View Abstract
28-Mar-09 Pechala's Reports Lubomir Pechala ONCOLYTICS BIOTECH INC (ONCY=US) 2-weeks forecast 1 $10 View Abstract
27-Mar-09 Zacks Investment Research Inc. N/A ONCOLYTICS BIO (ONCY) Zacks Company Snapshot 1 $10 View Abstract

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.